+关注
海天辽阔
暂无个人介绍
IP属地：未知
1
关注
1
粉丝
0
主题
0
勋章
主贴
热门
海天辽阔
2020-02-12
$博琪医药(BIMI)$
期待回升
海天辽阔
2020-02-05
赞赞赞
@瑶林琼树:【利好！BIMI】一亿元完成重大并购 有望领跑医药股市
海天辽阔
2020-02-04
$博琪医药(BIMI)$
期待暴涨
海天辽阔
2020-02-03
$博琪医药(BIMI)$
之前都要放弃了，这样看还有上涨的趋势，好多人都看到
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3543814210802799","uuid":"3543814210802799","gmtCreate":1580720188200,"gmtModify":1580800688647,"name":"海天辽阔","pinyin":"htlkhaitianliaokuo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":1,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":917008043,"gmtCreate":1581519557782,"gmtModify":1704344406141,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待回升","listText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待回升","text":"$博琪医药(BIMI)$期待回升","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/917008043","isVote":1,"tweetType":1,"viewCount":2006,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":915414320,"gmtCreate":1580910300660,"gmtModify":1704342819761,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"赞赞赞","listText":"赞赞赞","text":"赞赞赞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/915414320","repostId":"915525838","repostType":1,"repost":{"id":915525838,"gmtCreate":1580887397324,"gmtModify":1704342722379,"author":{"id":"3543745314313397","authorId":"3543745314313397","name":"瑶林琼树","avatar":"https://static.tigerbbs.com/4420af6b367b331a03ee0c80e431062a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543745314313397","authorIdStr":"3543745314313397"},"themes":[],"title":"【利好！BIMI】一亿元完成重大并购 有望领跑医药股市","htmlText":" 周一（2月3日）A股开盘，指数大跌，沪指开盘跌超8%，多数个股跌停，但有一个板块，仍出现大涨，就是肺炎概念板块，多只个股涨停，其中仅上市三个交易日的科创板公司洁特生物涨幅超约30%。 美股方面，热门中概医疗概念股上涨，博琪医药(BIMI.US)涨超72%，联络智能(LLIT.US)涨超25%，惠普森医药(CPHI.US)涨超11%，泰和诚医疗(CCM.US)涨超8%，市场意愿强烈，涨势超预期。 公开资料显示，博琪国际医药有限公司（简称“博琪医药(BIMI.US)”）是一家总部位于中国的连锁药房，拥有300多家门店，包括直营店和加盟店。药房通常销售大约6000种药物，其中600多种是根据独家销售安排进行的。该公司拥有1万多名会员客户，每名会员平均每年花费3000-5000元人民币。博琪医药(BIMI.US)将塑造成为全球最大的医疗互联网+高科技公司，持续推动数字化在医疗领域的渗透。 2月3日开盘后，博琪医药(BIMI.US)一度涨超至40%。以上。并伴随重大利好出现。 据悉，博琪医药于2019年12月与中国医疗器械经销商重庆冠赞科技达成并购协议，以1亿人民币的价格购买重庆冠赞科所有已发行和流通股，从而为中国西南地区200多家全方位服务的专科医院提供服务。而博琪医药与重庆冠赞科技的协议中提到重庆冠赞将收购重庆舒德药业80%的股权。重庆舒德药业是一家覆盖全国3000家药店、3000多家诊所和50家民营和公立医院的中国医疗器械经销商。而此次收购后博琪医药可与重庆冠赞科技和重庆舒德药业分享分销渠道。 此外，包括联环药业、哈药股份、泰达股份等多只个股封","listText":" 周一（2月3日）A股开盘，指数大跌，沪指开盘跌超8%，多数个股跌停，但有一个板块，仍出现大涨，就是肺炎概念板块，多只个股涨停，其中仅上市三个交易日的科创板公司洁特生物涨幅超约30%。 美股方面，热门中概医疗概念股上涨，博琪医药(BIMI.US)涨超72%，联络智能(LLIT.US)涨超25%，惠普森医药(CPHI.US)涨超11%，泰和诚医疗(CCM.US)涨超8%，市场意愿强烈，涨势超预期。 公开资料显示，博琪国际医药有限公司（简称“博琪医药(BIMI.US)”）是一家总部位于中国的连锁药房，拥有300多家门店，包括直营店和加盟店。药房通常销售大约6000种药物，其中600多种是根据独家销售安排进行的。该公司拥有1万多名会员客户，每名会员平均每年花费3000-5000元人民币。博琪医药(BIMI.US)将塑造成为全球最大的医疗互联网+高科技公司，持续推动数字化在医疗领域的渗透。 2月3日开盘后，博琪医药(BIMI.US)一度涨超至40%。以上。并伴随重大利好出现。 据悉，博琪医药于2019年12月与中国医疗器械经销商重庆冠赞科技达成并购协议，以1亿人民币的价格购买重庆冠赞科所有已发行和流通股，从而为中国西南地区200多家全方位服务的专科医院提供服务。而博琪医药与重庆冠赞科技的协议中提到重庆冠赞将收购重庆舒德药业80%的股权。重庆舒德药业是一家覆盖全国3000家药店、3000多家诊所和50家民营和公立医院的中国医疗器械经销商。而此次收购后博琪医药可与重庆冠赞科技和重庆舒德药业分享分销渠道。 此外，包括联环药业、哈药股份、泰达股份等多只个股封","text":"周一（2月3日）A股开盘，指数大跌，沪指开盘跌超8%，多数个股跌停，但有一个板块，仍出现大涨，就是肺炎概念板块，多只个股涨停，其中仅上市三个交易日的科创板公司洁特生物涨幅超约30%。 美股方面，热门中概医疗概念股上涨，博琪医药(BIMI.US)涨超72%，联络智能(LLIT.US)涨超25%，惠普森医药(CPHI.US)涨超11%，泰和诚医疗(CCM.US)涨超8%，市场意愿强烈，涨势超预期。 公开资料显示，博琪国际医药有限公司（简称“博琪医药(BIMI.US)”）是一家总部位于中国的连锁药房，拥有300多家门店，包括直营店和加盟店。药房通常销售大约6000种药物，其中600多种是根据独家销售安排进行的。该公司拥有1万多名会员客户，每名会员平均每年花费3000-5000元人民币。博琪医药(BIMI.US)将塑造成为全球最大的医疗互联网+高科技公司，持续推动数字化在医疗领域的渗透。 2月3日开盘后，博琪医药(BIMI.US)一度涨超至40%。以上。并伴随重大利好出现。 据悉，博琪医药于2019年12月与中国医疗器械经销商重庆冠赞科技达成并购协议，以1亿人民币的价格购买重庆冠赞科所有已发行和流通股，从而为中国西南地区200多家全方位服务的专科医院提供服务。而博琪医药与重庆冠赞科技的协议中提到重庆冠赞将收购重庆舒德药业80%的股权。重庆舒德药业是一家覆盖全国3000家药店、3000多家诊所和50家民营和公立医院的中国医疗器械经销商。而此次收购后博琪医药可与重庆冠赞科技和重庆舒德药业分享分销渠道。 此外，包括联环药业、哈药股份、泰达股份等多只个股封","images":[{"img":"https://static.tigerbbs.com/ff4927c82d7a2ecd644272d070633216","width":"554","height":"626"},{"img":"https://static.tigerbbs.com/1e162013ff33c204f770c071f13fd8fc","width":"553","height":"630"},{"img":"https://static.tigerbbs.com/0dc1958809373a62d35fb97d85b5efcb","width":"523","height":"825"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/915525838","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":915658391,"gmtCreate":1580825079313,"gmtModify":1704342457215,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待暴涨","listText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待暴涨","text":"$博琪医药(BIMI)$期待暴涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/915658391","isVote":1,"tweetType":1,"viewCount":1071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":915351987,"gmtCreate":1580732342449,"gmtModify":1704342038793,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>之前都要放弃了，这样看还有上涨的趋势，好多人都看到","listText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>之前都要放弃了，这样看还有上涨的趋势，好多人都看到","text":"$博琪医药(BIMI)$之前都要放弃了，这样看还有上涨的趋势，好多人都看到","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/915351987","isVote":1,"tweetType":1,"viewCount":1240,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":915658391,"gmtCreate":1580825079313,"gmtModify":1704342457215,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待暴涨","listText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待暴涨","text":"$博琪医药(BIMI)$期待暴涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/915658391","isVote":1,"tweetType":1,"viewCount":1071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":915351987,"gmtCreate":1580732342449,"gmtModify":1704342038793,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>之前都要放弃了，这样看还有上涨的趋势，好多人都看到","listText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>之前都要放弃了，这样看还有上涨的趋势，好多人都看到","text":"$博琪医药(BIMI)$之前都要放弃了，这样看还有上涨的趋势，好多人都看到","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/915351987","isVote":1,"tweetType":1,"viewCount":1240,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":917008043,"gmtCreate":1581519557782,"gmtModify":1704344406141,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待回升","listText":"<a href=\"https://laohu8.com/S/BIMI\">$博琪医药(BIMI)$</a>期待回升","text":"$博琪医药(BIMI)$期待回升","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/917008043","isVote":1,"tweetType":1,"viewCount":2006,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":915414320,"gmtCreate":1580910300660,"gmtModify":1704342819761,"author":{"id":"3543814210802799","authorId":"3543814210802799","name":"海天辽阔","avatar":"https://static.tigerbbs.com/b3b3178b3b9831100cc2b0ebd98a2f76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543814210802799","authorIdStr":"3543814210802799"},"themes":[],"htmlText":"赞赞赞","listText":"赞赞赞","text":"赞赞赞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/915414320","repostId":"915525838","repostType":1,"repost":{"id":915525838,"gmtCreate":1580887397324,"gmtModify":1704342722379,"author":{"id":"3543745314313397","authorId":"3543745314313397","name":"瑶林琼树","avatar":"https://static.tigerbbs.com/4420af6b367b331a03ee0c80e431062a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3543745314313397","authorIdStr":"3543745314313397"},"themes":[],"title":"【利好！BIMI】一亿元完成重大并购 有望领跑医药股市","htmlText":" 周一（2月3日）A股开盘，指数大跌，沪指开盘跌超8%，多数个股跌停，但有一个板块，仍出现大涨，就是肺炎概念板块，多只个股涨停，其中仅上市三个交易日的科创板公司洁特生物涨幅超约30%。 美股方面，热门中概医疗概念股上涨，博琪医药(BIMI.US)涨超72%，联络智能(LLIT.US)涨超25%，惠普森医药(CPHI.US)涨超11%，泰和诚医疗(CCM.US)涨超8%，市场意愿强烈，涨势超预期。 公开资料显示，博琪国际医药有限公司（简称“博琪医药(BIMI.US)”）是一家总部位于中国的连锁药房，拥有300多家门店，包括直营店和加盟店。药房通常销售大约6000种药物，其中600多种是根据独家销售安排进行的。该公司拥有1万多名会员客户，每名会员平均每年花费3000-5000元人民币。博琪医药(BIMI.US)将塑造成为全球最大的医疗互联网+高科技公司，持续推动数字化在医疗领域的渗透。 2月3日开盘后，博琪医药(BIMI.US)一度涨超至40%。以上。并伴随重大利好出现。 据悉，博琪医药于2019年12月与中国医疗器械经销商重庆冠赞科技达成并购协议，以1亿人民币的价格购买重庆冠赞科所有已发行和流通股，从而为中国西南地区200多家全方位服务的专科医院提供服务。而博琪医药与重庆冠赞科技的协议中提到重庆冠赞将收购重庆舒德药业80%的股权。重庆舒德药业是一家覆盖全国3000家药店、3000多家诊所和50家民营和公立医院的中国医疗器械经销商。而此次收购后博琪医药可与重庆冠赞科技和重庆舒德药业分享分销渠道。 此外，包括联环药业、哈药股份、泰达股份等多只个股封","listText":" 周一（2月3日）A股开盘，指数大跌，沪指开盘跌超8%，多数个股跌停，但有一个板块，仍出现大涨，就是肺炎概念板块，多只个股涨停，其中仅上市三个交易日的科创板公司洁特生物涨幅超约30%。 美股方面，热门中概医疗概念股上涨，博琪医药(BIMI.US)涨超72%，联络智能(LLIT.US)涨超25%，惠普森医药(CPHI.US)涨超11%，泰和诚医疗(CCM.US)涨超8%，市场意愿强烈，涨势超预期。 公开资料显示，博琪国际医药有限公司（简称“博琪医药(BIMI.US)”）是一家总部位于中国的连锁药房，拥有300多家门店，包括直营店和加盟店。药房通常销售大约6000种药物，其中600多种是根据独家销售安排进行的。该公司拥有1万多名会员客户，每名会员平均每年花费3000-5000元人民币。博琪医药(BIMI.US)将塑造成为全球最大的医疗互联网+高科技公司，持续推动数字化在医疗领域的渗透。 2月3日开盘后，博琪医药(BIMI.US)一度涨超至40%。以上。并伴随重大利好出现。 据悉，博琪医药于2019年12月与中国医疗器械经销商重庆冠赞科技达成并购协议，以1亿人民币的价格购买重庆冠赞科所有已发行和流通股，从而为中国西南地区200多家全方位服务的专科医院提供服务。而博琪医药与重庆冠赞科技的协议中提到重庆冠赞将收购重庆舒德药业80%的股权。重庆舒德药业是一家覆盖全国3000家药店、3000多家诊所和50家民营和公立医院的中国医疗器械经销商。而此次收购后博琪医药可与重庆冠赞科技和重庆舒德药业分享分销渠道。 此外，包括联环药业、哈药股份、泰达股份等多只个股封","text":"周一（2月3日）A股开盘，指数大跌，沪指开盘跌超8%，多数个股跌停，但有一个板块，仍出现大涨，就是肺炎概念板块，多只个股涨停，其中仅上市三个交易日的科创板公司洁特生物涨幅超约30%。 美股方面，热门中概医疗概念股上涨，博琪医药(BIMI.US)涨超72%，联络智能(LLIT.US)涨超25%，惠普森医药(CPHI.US)涨超11%，泰和诚医疗(CCM.US)涨超8%，市场意愿强烈，涨势超预期。 公开资料显示，博琪国际医药有限公司（简称“博琪医药(BIMI.US)”）是一家总部位于中国的连锁药房，拥有300多家门店，包括直营店和加盟店。药房通常销售大约6000种药物，其中600多种是根据独家销售安排进行的。该公司拥有1万多名会员客户，每名会员平均每年花费3000-5000元人民币。博琪医药(BIMI.US)将塑造成为全球最大的医疗互联网+高科技公司，持续推动数字化在医疗领域的渗透。 2月3日开盘后，博琪医药(BIMI.US)一度涨超至40%。以上。并伴随重大利好出现。 据悉，博琪医药于2019年12月与中国医疗器械经销商重庆冠赞科技达成并购协议，以1亿人民币的价格购买重庆冠赞科所有已发行和流通股，从而为中国西南地区200多家全方位服务的专科医院提供服务。而博琪医药与重庆冠赞科技的协议中提到重庆冠赞将收购重庆舒德药业80%的股权。重庆舒德药业是一家覆盖全国3000家药店、3000多家诊所和50家民营和公立医院的中国医疗器械经销商。而此次收购后博琪医药可与重庆冠赞科技和重庆舒德药业分享分销渠道。 此外，包括联环药业、哈药股份、泰达股份等多只个股封","images":[{"img":"https://static.tigerbbs.com/ff4927c82d7a2ecd644272d070633216","width":"554","height":"626"},{"img":"https://static.tigerbbs.com/1e162013ff33c204f770c071f13fd8fc","width":"553","height":"630"},{"img":"https://static.tigerbbs.com/0dc1958809373a62d35fb97d85b5efcb","width":"523","height":"825"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/915525838","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
